Literature DB >> 12424071

Totally implantable venous-access ports: local problems and extravasation injury.

Sidika Kurul1, Pinar Saip, Tulay Aydin.   

Abstract

Totally implantable venous-access ports (TIVAPs) are valuable instruments for long-term intravenous treatment of patients with cancer, but implantation and use of these devices are each associated with complications. In addition to the perioperative problems, long-term complications can arise; these can be classified in five categories-catheter malfunction, catheter-related venous thrombosis, catheter-related infection, port-related complications, and extravasation injury. Such complications reduce the benefits of reliable access to the venous system in patients with malignant tumours. The vast majority of such disadvantages are attributable to inexpert handling of ports and, therefore, should be avoidable. TIVAP placement procedures and TIVAP complications are discussed in this review, with special emphasis on local problems and extravasation injuries. To obtain maximum benefit from TIVAPs, all health-care personnel must be familiar with the use and routine maintenance procedures of the devices and treatment options for catheter-related complications.

Entities:  

Mesh:

Year:  2002        PMID: 12424071     DOI: 10.1016/s1470-2045(02)00905-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  34 in total

1.  Intrapleural extravasation of epirubicin, 5-fluouracil, and cyclophosphamide, treated with dexrazoxane.

Authors:  Joris W F Uges; Albert M Vollaard; Erik B Wilms; Rolf E Brouwer
Journal:  Int J Clin Oncol       Date:  2006-12-25       Impact factor: 3.402

2.  Administration of intravenous iron complexes on implantable central venous access port in cancer patients in France: the FERPAC survey.

Authors:  Nicolas Janus; Florian Scotte; Jean-Baptiste Rey; Sabine Amet; Laurence Rouillon; Lorraine Zakin; Lamine Mahi; Gilbert Deray; Vincent Launay-Vacher
Journal:  Support Care Cancer       Date:  2013-05-29       Impact factor: 3.603

3.  Femoral placement of totally implantable venous power ports as an alternative implantation site for patients with central vein occlusions.

Authors:  Jan P Goltz; Hendrik Janssen; Bernhard Petritsch; Ralph Kickuth
Journal:  Support Care Cancer       Date:  2013-09-24       Impact factor: 3.603

4.  Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trial.

Authors:  Scott A Irwin; Alana Iglewicz; Richard A Nelesen; Jessica Y Lo; Connie H Carr; Sheilani D Romero; Linda S Lloyd
Journal:  J Palliat Med       Date:  2013-06-27       Impact factor: 2.947

5.  Fracture and migration of implantable venous access port catheters: Cause analysis and management of 4 cases.

Authors:  Shu-Ping Xiao; Bin Xiong; Jun Chu; Xiao-Fang Li; Qi Yao; Chuan-Sheng Zheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-10-22

6.  A comparison of outcomes and complications of totally implantable access port through the internal jugular vein versus the subclavian vein.

Authors:  Yoshinobu Nagasawa; Tomoharu Shimizu; Hiromichi Sonoda; Eiji Mekata; Masato Wakabayashi; Hiroyuki Ohta; Satoshi Murata; Tsuyoshi Mori; Shigeyuki Naka; Tohru Tani
Journal:  Int Surg       Date:  2014 Mar-Apr

7.  Choosing the appropriate side for subcutaneous port catheter placement in patients with mastectomy: ipsilateral or contralateral?

Authors:  Omer Fatih Nas; Kadir Hacikurt; Ahmet Kaya; Nurullah Dogan; Bekir Sanal; Guven Ozkaya; Halit Ziya Dundar; Cuneyt Erdogan
Journal:  Radiol Med       Date:  2017-02-17       Impact factor: 3.469

8.  Late complications associated with totally implantable venous access port implantation via the internal jugular vein.

Authors:  Shigeaki Tsuruta; Yasutomo Goto; Hideo Miyake; Hidemasa Nagai; Yuichiro Yoshioka; Norihiro Yuasa; Junichi Takamizawa
Journal:  Support Care Cancer       Date:  2019-11-14       Impact factor: 3.603

9.  Adverse effects of parenteral antimicrobial therapy for chronic bone infections.

Authors:  C Pulcini; T Couadau; E Bernard; A Lorthat-Jacob; T Bauer; E Cua; V Mondain; R-M Chichmanian; P Dellamonica; P-M Roger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-09-26       Impact factor: 3.267

10.  Totally Implantable Venous Access Devices in Children Requiring Long-Term Chemotherapy: Analysis of Outcome in 122 Children from a Single Institution.

Authors:  Gowri Shankar; Vinay Jadhav; Narendra Babu
Journal:  Indian J Surg Oncol       Date:  2016-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.